Matches in Wikidata for { <http://www.wikidata.org/entity/Q57113167> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q57113167 description "article scientifique publié en 2018" @default.
- Q57113167 description "artículu científicu espublizáu en marzu de 2018" @default.
- Q57113167 description "im Mai 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57113167 description "scientific article published on 21 March 2018" @default.
- Q57113167 description "wetenschappelijk artikel" @default.
- Q57113167 description "наукова стаття, опублікована в травні 2018" @default.
- Q57113167 name "RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101" @default.
- Q57113167 name "RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101" @default.
- Q57113167 type Item @default.
- Q57113167 label "RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101" @default.
- Q57113167 label "RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101" @default.
- Q57113167 prefLabel "RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101" @default.
- Q57113167 prefLabel "RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101" @default.
- Q57113167 P1433 Q57113167-2169F72F-8B1F-467F-9808-1BF8CDACD7C9 @default.
- Q57113167 P1476 Q57113167-A1F91875-5F44-4072-9EE4-ECC07C7C2E06 @default.
- Q57113167 P2093 Q57113167-72D35780-72EE-4FEE-89AD-1F981781535E @default.
- Q57113167 P304 Q57113167-52666319-546E-4DB8-9BB5-A378DDB7BE57 @default.
- Q57113167 P31 Q57113167-2D47B3D7-7D48-4566-9867-E7B02F120269 @default.
- Q57113167 P356 Q57113167-6B75A18C-E393-4B99-BC5A-F11BD3345575 @default.
- Q57113167 P407 Q57113167-0392AA70-B3AD-4C7A-A0BB-E0B325518A8A @default.
- Q57113167 P478 Q57113167-6C3AC8B3-A950-4792-B81F-7D38A516C90D @default.
- Q57113167 P50 Q57113167-CF6BF587-3175-4E40-A4DC-70DE2B91C6D8 @default.
- Q57113167 P577 Q57113167-921EA341-392E-41CC-A347-5C1AD9611FD9 @default.
- Q57113167 P698 Q57113167-D0AB2CB8-F1F5-446F-AD6D-D69D055011AA @default.
- Q57113167 P356 J.EJCA.2018.01.115 @default.
- Q57113167 P698 29573942 @default.
- Q57113167 P1433 Q332260 @default.
- Q57113167 P1476 "RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101" @default.
- Q57113167 P2093 "Zachary Klaassen" @default.
- Q57113167 P304 "216-217" @default.
- Q57113167 P31 Q13442814 @default.
- Q57113167 P356 "10.1016/J.EJCA.2018.01.115" @default.
- Q57113167 P407 Q1860 @default.
- Q57113167 P478 "94" @default.
- Q57113167 P50 Q87642258 @default.
- Q57113167 P577 "2018-03-21T00:00:00Z" @default.
- Q57113167 P698 "29573942" @default.